chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of an injection site reaction in a 5 year old female pt who received DTAP (Infanrix) for prophylaxis. The vaccine provider submitted this report directly to the local health department. On 04/17/03 the pt received the 5th dose of Infanrix in the left arm. On the same date, she received an injection of inactivated IPV in the left arm and an injection of MMRII in the right arm.  On 04/18/04, 24 hours post-immunization, the pt experienced an injection site reaction characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low-grade fever. The events resolved on 04/20/03.  The nurse considered the events were related to vaccination with Infanrix.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site inflammation, Injection site oedema, Injection site pain, Irritability, Musculoskeletal stiffness
Clinical narrative: This case was reported by a nurse and described the occurrence of an injection site reaction in a 5 year old male pt who received DTAP (Infanrix) for prophylaxis. The vaccine provider submitted this report directly to the local health department. On 04/17/03 the pt received the 5th dose of Infanrix in the left arm. On the same date, he received an injection of IPV in the left arm and an injection of MMRII in the right arm.  On 04/18/03, 24 hours post-immunization, the pt experienced an injection site reaction characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low-grade fever. The events resolved on 04/20/03.  The nurse considered the events were related to vaccination with Infanrix.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of an injection site reaction in a 5 year old male pt who received DTAP (Infanrix) for prophylaxis. The vaccine provider submitted this report directly to the local health department. On 04/17/03 the pt received the 5th dose of Infanrix in the left arm. On the same date, he received an injection of IPV in the left arm and an injection of MMRII in the right arm.  On 04/18/03, 24 hours post-immunization, the pt experienced an injection site reaction characterized by pain, swelling and inflammation. The pt's left arm was stiff. The pt also experienced irritability and low-grade fever. The events resolved on 04/20/03.  The nurse considered the events were related to vaccination with Infanrix.
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of a possible allergic reaction in a 5 year old female pt who received DTAP (Infanrix) for prophylaxis. On an unspecified date, the pt received the 5th dose of Infanrix (Lot # DTPA586B9).  On 03/18/03, at an unspecified time post-immunization, the pt experienced a possible allergic reaction characterized by swelling and redness at the injection site. The pt was seen by the physician, who prescribed Zyrtec and Cefzil. The event resolved on 03/25/03.  The reporter considered the event to be related to vaccination with Infanrix.
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of a possible allergic reaction in a 5 year old male pt who received DTAP (Infanrix) for prophylaxis. On an unspecified date, the pt received the 5th dose of Infanrix (Lot # DTPA586B9).  On 03/24/03, at an unspecified time post-immunization, the pt experienced a possible allergic reaction characterized by swelling and redness at the injection site. The event resolved on 03/28/03.  The reporting nurse considered the event was related to vaccination with Infanrix.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of a possible allergic reaction in a 4 year old female pt who received DTAP (Infanrix) for prophylaxis. On an unspecified date, the pt received the 5th dose of Infanrix (Lot # DTPA586B9).  On 02/20/03, at an unspecified time post-immunization, the pt experienced a possible allergic reaction characterized by swelling and redness at the injection site. The event resolved on 02/27/03.  The reporting nurse considered the event was related to vaccination with Infanrix.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of a possible allergic reaction in a 4 year old male pt who received DTAP (Infanrix) for prophylaxis. On an unspecified date, the pt received the 5th dose of Infanrix (Lot  # DTPA586B9).  On 04/01/03, at an unspecified time post-immunization, the pt experienced a possible allergic reaction characterized by swelling and redness at the injection site. The pt was seen by the physician, who prescribed Zyrtec. The event resolved after an unspecified period of time. The reporting nurse considered the event was related to vaccination with Infanrix.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Hypersensitivity, Injection site erythema, Injection site swelling
Clinical narrative: This case was reported by a nurse and described the occurrence of a possible allergic reaction in a 4 year old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On an unspecified date, the patient received the fifth dose of Infanrix (lot DTPA586B9). On 4/28/03, at an unspecified time post immunization, the patient experienced a possible allergic reaction characterized by swelling and redness at the injection site. The patient was seen by the physician, who prescribed prednisolone sodium phosphate and cephalexin. The event resolved on 5/3/03. The reporting nurse considered the event was related to vaccination with Infanrix.
Age: 1.25
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This case was reported by a health professional and described the occurrence of an injection site reaction in a 15 month old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 6/6/03, the patient received the fourth dose of Infanrix (lot DTPA598A2). On 6/7/03, 24 hours post immunization, the patient experienced an injection site reaction characterized by swelling and redness. The patient was seen by the physician, who prescribed an unspecified antibiotic. The events resolved within 48 hours of initiating antibiotic therapy. The reporter considered the injection site reaction to be related to Infanrix administration.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema
Clinical narrative: This case was reported by a nurse and described the occurrence of injection site redness in a 4 year old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. In June 2003, the patient received the fifth dose of Infanrix. Subsequently, the patient developed a golf ball size red area on the upper arm. The patient was seen by the physician. The outcome of the event is unknown. Comment: The reporter indicated that three additional patients experienced more redness than normal following receipt of Infanrix lot DTPA590A9 for the fifth dose in the immunization series. However, these subjects are not presently identifiable.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Oedema peripheral
Clinical narrative: This case was reported by a nurse and described the occurrence of limb swelling in a 4 year old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. In June 2003, the patient received the fifth dose of Infanrix. Subsequently, the patient's whole upper arm was very swollen and was very red and hard. The patient was seen by the physician. The outcome of the events is unknown.
Sex: U
Vaccine: DTAP
Symptoms: Oedema peripheral
Clinical narrative: This case was reported by a nurse and described the occurrence of arm swelling in a kindergarten-aged child who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The patient's medical history, concurrent conditions, and concurrent medications were not reported. In May 2003, the patient received an injection of Infanrix. In May 2003, at an unspecified time post immunization, the patient developed arm swelling. The patient was seen by the physician. The event was unresolved as of 5/15/03. The nurse considered the event was possibly related to vaccination with Infanrix
Age: 3.0
Sex: U
Vaccine: DTAP
Symptoms: Oedema peripheral
Clinical narrative: This case was reported by a health professional and described the occurrence of limb swelling in a 3 year old patient who received diphtheria and tetanus toxoid and acellular pertussis vaccine absorbed for prophylaxis. The patient's medical history, concurrent conditions and concurrent medications were not reported. On an unspecified date in May 2003, the patient received Infanrix. Subsequently, the patient experienced hugely abnormal limb swelling. The patient was seen by the physician. As of 5/15/03, the event persisted. The reporter considered the event was possibly related to vaccination with Infanrix.
Age: 1.25
Sex: U
Vaccine: DTAP
Symptoms: Oedema peripheral
Clinical narrative: This case was reported by a health professional and described the occurrence of limb swelling in a 15 month old patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The patient's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date in May 2003, the patient received Infanrix. Subsequently, the patient experienced hugely abnormal limb swelling. The patient was seen by the physician. As of 5/15/03, the event persisted. The reporter considered the event was possibly related to vaccination with Infanrix.
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling, Lethargy, Pruritus, Pyrexia
Clinical narrative: This case was reported by a physician and described the occurrence of lethargy in a patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The patient's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date, the patient received Infanrix. At an unknown time post immunization, the patient experienced lethargy, fever of 101 to 102 degrees F, and an injection site reaction characterized by swelling, redness, and itching. The patient was seen by the physician who prescribed cold compress, paracetamol and applications of ice. The events were unresolved as of 5/23/03. The reporting physician considered the events were probably related to vaccination with Infanrix lot DTPA574A2. Comment: The reporter indicated that three children experienced these events after receiving Infanrix lot DTPA574A2. However, they are not presently identifiable.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Medication error, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 4 year old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The patient had no relevant medical history, concurrent conditions, or concurrent medications. On 7/2/03 the patient received the fifth dose of Infanrix (lot DTPA578A9). This vaccine had inadvertently been left unrefrigerated for an unspecified period of time. On the same date, she also received injections of MMR and inactivated poliomyelitis virus vaccine. On 7/3/03, 24 hours post immunization, the patient developed fever and an injection site reaction characterized by redness and swelling. The patient was seen by the physician. The nurse considered the events were probably related to vaccination with Infanrix.
Age: 0.2
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling, Medication error, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 2 month old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The patient had no relevant medical history, concurrent conditions, or concurrent medications. On 7/2/03, the patient received the first dose of Infanrix (lot DTPA578A9). This vaccine had inadvertently been left unrefrigerated for an unspecified period of time. On 7/3/03, 24 hours post immunization, the patient developed a fever and an injection site reaction characterized by swelling and redness. The patient was seen by the physician. The nurse considered the events were probably related to vaccination with Infanrix.
Age: 0.17
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Medication error, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 2 month old male pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. The pt had no relevant medical history, concurrent conditions, or concurrent medications. On 02July2003, the pt received the first dose of Infanrix. This vaccine had inadvertently been left unrefrigerated for an unspecified period of time. On the same date, he also received his first injections of Haemophilus influenzae type b conjugate vaccine, inactivated poliomyelitis virus vaccine (IPOL), and 7 valent pneumococcal conjugate vaccine (Prevnar). On 03July2003, 24 hours post immunization, the pt developed a fever and an injection site reaction characterized by swelling and redness. The pt was seen by the physician. The nurse considered the events were probably related to vaccination with Infanrix.
Sex: U
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Medication error, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix) for prophylaxis. On 30 June 2003 the patient received an injection of Infanrix (lot DTPA578A9). This vaccine had inadvertently been left unrefrigerated for an unspecified period of time. On the same date, the patient also received injections of Haemophilus influenzae type b conjugate vaccine (manufacturer unknown), inactivated poliomyelitis virus vaccine (IPOL), and 7-valent pneumococcal conjugate vaccine. On 01 July 2003, 24
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Medication error, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On 01July2003 the pt received an injection of Infanrix. This vaccine had been inadvertently left unrefrigerated for an unspecified period of time. On 02July2003, 24 hours post-immunization, the pt developed a fever and an injection site reaction characterized by redness and swelling. The pt was seen by the physician. The nurse considered the events were probably related to vaccination with Infanrix.
Age: 1.5
Sex: U
Vaccine: DTAP
Symptoms: Cellulitis
Clinical narrative: This case was reported by a nurse and described the occurrence of injection site cellulitis in an 18 month old pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On an unspecified date, the pt received Infanrix. At an unknown time, post immunization, the pt developed a type of cellulitis or swelling of the arm. The outcome of the event is unknown.
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Pruritus
Clinical narrative: This case was reported by a physician and described the occurrence of an injection site reaction in a pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  On an unspecified date, the pt received the 5th dose of Infanrix. At an unknown time post immunization, the pt experienced an injection site reaction characterized by swelling, redness, and itching. A healthcare professional was consulted regarding the events. The events resolved after an unspecified period of time. Comment: The reporter indicated that three subjects experienced these events following receipt of Infanrix lot 594A2 for the fifth dose in the immunization series. However, the subjects are not presently identifiable.
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This case was reported by a physician and described the occurrence of an injection site reaction in a pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On an unspecified date, the pt received the 5th dose of Infanrix. At an unknown time post-immunization, the pt experienced an injection site reaction characterized by a 3 inch area of redness and swelling. The outcome of the events is unknown. The reporting physician considered the events were probably related to vaccination with Infanrix.
Age: 1.33
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This case was reported by a health professional and described the occurrence of an injection site reaction in a 16 month old male pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On 03Jun03 the pt received the 4th dose of Infanrix. On 04Jun03, 24 hours post-immunization, the pt experienced an injection site reaction characterized by swelling and redness. The pt was seen by the physician, who prescribed an unspecified antibiotic. The events resolved within 48 hours of initiating antibiotic therapy. The reporter considered the injection site reaction to be related to Infanrix administration.
Age: 1.25
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This case was reported by a health professional and described the occurrence of an injection site reaction in a 15 month old female pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On 17Jun03 the pt received the 4th dose of Infanrix. On 18Jun03, 24 hours post-immunization, the pt experienced an injection site reaction characterized by swelling and redness. The pt was seen by the physician, who prescribed an unspecified antibiotic. The events resolved within 48 hours of initiating antibiotic therapy. The reporter considered the injection site reaction to be related to vaccination with Infanrix.
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This case was reported by a health professional and described the occurrence of an injection site reaction in a 5 year old female pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On 02May03 the pt received the 5th dose of Infanrix. On 03May03, 24 hours post-immunization, the pt experienced an injection site reaction characterized by swelling and redness. The pt was seen by the physician, who prescribed an unspecified antibiotic. The events resolved within 48 hours of initiating antibiotic therapy. The reporter considered the injection site reaction to be related to vaccination with Infanrix.
Age: 1.6
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a health professional and described the occurrence of an injection site reaction in a 15 month old male pt who received DTAP (Infanrix) for prophylaxis. On 06/06/03 the pt received the 4th dose of Infanrix (Lot# DTPA598A2).  On 06/07/03, 24 hours post-immunization, the pt experienced an injection site reaction characterized by swelling and redness. The pt was seen by the physician. The injection site reaction resolved on an unspecified date. The reporter considered the injection site reaction to be related to Infanrix administration.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Convulsion
Clinical narrative: This case described the occurrence of seizures in a 4 year old female pt who received DTAP for prophylaxis. This report was received from the pt's mother and has not been verified by a physician or other health care professional.  On an unspecified date in January 2002 the pt received the 5th dose of Infanrix. On the same day, she also received injections of IPV and MMRII. Later that day, the pt experienced four seizures within a 24 hour period.  The pt was seen by a physician, who prescribed an unspecified anticonvulsant. The mother reported that the pt had no further seizures; however, she continued to take the anticonvulsant as of 07/14/03.  Seizures are considered manufacturer medically serious (OMIC).
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: A nurse reported the occurrence of an injection site reaction in a 4 year old female who was vaccinated with DTAP (Infanrix) for prophylaxis. The vaccine provider submitted this report directly to VAERS.  The pt had no medical history, adverse experiences following receipt of previous immunizations, or concurrent medications. The pt had a cold at the time of immunization. The pt received her fifth injection of Infanrix (Lot # DTPA592A9) on 04/15/03 into her left arm. She also received injections of IPV and MMRII into her right arm. On 04/16/03, 1 day post-immunization, she developed an injection site reaction characterized by redness and swelling that extended from the injection site to the elbow. The events resolved. The nurse considered the events to be related to Infanrix administration.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Abnormal behaviour, Injection site erythema, Injection site induration, Similar reaction on previous exposure to drug
Clinical narrative: A nurse reported the occurrence of an injection site reaction in a 4 year old female who was inadvertently vaccinated with DTAP (Infanrix) for prophylaxis. The vaccine provider submitted this report directly to VAERS.  The pt had no medical history, concurrent conditions, or concurrent medications. The pt received the first injection of DTAP on 07/22/99.  That day, she cried for five hours. The pertussis immunization series was discontinued. On an unspecified date in 2003, the pt inadvertently received an injection of Infanrix (Lot # DTPA575A2) for the fifth dose in the DT immunization series. At an unspecified time post-immunization, she developed an injection site reaction characterized by redness and induration. She also had a "grump demeanor". The events resolved after 72 hours. The  nurse considered the events to be related to Infanrix administration.
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a pharmacist and described the occurrence of an injection site reaction in a pt who received DTAP (Infanrix) for prophylaxis. On an unspecified date in 2003, the pt received the fifth injection of Infanrix from either Lot # DTPA592B9 or DTPA592A9.  At an unknown time post-immunization, the pt experienced an injection site reaction characterized by "swelling spreading down the arm" and redness. The outcome of the events was unknown. The reporting pharmacist considered the events were probably related to vaccination with Infanrix. Comment: The reporter indicated that 15 to 17 children experienced these events following receipt of Infanrix Lots DTPA592B9 & DTPA592A9 for the fifth dose in the immunization series. However, they are not presently identifiable.
Age: 1.6
Sex: M
Vaccine: DTAP, HEPA, IPV
Symptoms: Cellulitis, Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of injection site cellulitis in an 18 month old male pt who received DTAP (Infanrix) for prophylaxis. On 07/15/03 the pt received the 4th dose of Infanrix (Lot# DTPA596A2) in the left leg. On the same date, he also received injections of hepatitis A vaccine inactivated (Havrix) in the left leg and IPV at an unspecified site. Havrix is not recommended for immunizing individuals less than 2 years of age. On 07/17/03, two days post-immunization, the pt's left leg "was very red and swollen from the injection site on the thigh down to the calf." The pt was seen by the physician who made a diagnosis of cellulitis and prescribed an unspecified antibiotic. The injection site cellulitis began to respond after two days of therapy, and resolved after an unspecified period of time. The reporter considered the event to be related to vaccination with Infanrix.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Cellulitis, Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of injection site cellulitis in a 4 year old female pt who received DTAP (Infanrix) for prophylaxis. On 07/15/03, the pt received the 5th dose of Infanrix (Lot# DTPA596A2).  On the same date, she also received an injection of IPV. On 07/16/03, 1 day post-immunization, the pt developed redness and swelling at the Infanrix injection site, which "extended down the arm". The pt was seen by the physician who made a diagnosis of injection site cellulitis and prescribed an unspecified antibiotic. The injection site cellulitis began to respond after two days of therapy, and resolved after an unspecified period of time. The reporter considered the event to be related to vaccination with Infanrix.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of an injection site reaction in an 5 year old male pt who received DTAP (Infanrix) for prophylaxis. On 07/22/03 the pt received the 4th dose of Infanrix (Lot # DTPA592B9) in the left arm.  On the same date he also received an injection of IPV. On 07/23/03, 1 day post-immunization, the parents noticed that the pt had developed an injection site reaction characterized by a  "large" area of redness and swelling at the site of Infanrix administration. The parents administered Tylenol and applied ice to the area. The pt was seen by the physician. The event resolved after an unspecified period of time. The reporter considered the event to be unrelated to vaccination with Infanrix.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of an injection site reaction in a 5 year old male pt who received DTAP (Infanrix) for prophylaxis. On 07/21/03, the pt received the 5th dose of Infanrix (Lot# DTPA592B9) in the left arm.  On the same date, he also received an injection of IPV in the left arm, and an injection of MMRII in the right arm. On 07/22/03, 1 day post-immunization, the parents noticed that the pt had developed an injection site reaction characterized by an area of swelling and redness that was the "size of a grapefruit".  On 07/23/03, the pt was seen by the physician, who administered Benadryl and prescribed applications of ice. The outcomes of the events were unknown.
Age: 0.08
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site warmth, Oedema, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of limb swelling in a 19-month old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix) for prophylaxis. On 27 May 2003, the patient received Infanrix. Within 24 hours post-immunization on 28 May 2003, the patient experienced a "more than usual reaction" characterized by a "large amount" of swelling extending form shoulder to elbow, redness, and warmth. She also developed a fever of 103 to 104 degrees Fahrenheit. Six days post immunization on 02 Jun 2003, the patient developed a rash all over her body. The patient was seen by the physician. The fever resolved within four days. The other events resolved after an unspecified period of time greater than four days. The nurse considered the limb swelling, injection site redness, and injection site warmth to be related to vaccination with Infanrix. She considered the fever and rash to be possibly related to Infanrix.
Age: 0.08
Sex: F
Vaccine: DTAP
Symptoms: Rash
Clinical narrative: This case was reported by a nurse and described the occurrence of limb swelling in a 19-month old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix) for prophylaxis. On 27 May 2003, the patient received Infanrix. Within 24 hours post-immunization on 28 May 2003, the patient experienced a "more than usual reaction" characterized by a "large amount" of swelling extending form shoulder to elbow, redness, and warmth. She also developed a fever of 103 to 104 degrees Fahrenheit. Six days post immunization on 02 Jun 2003, the patient developed a rash all over her body. The patient was seen by the physician. The fever resolved within four days. The other events resolved after an unspecified period of time greater than four days. The nurse considered the limb swelling, injection site redness, and injection site warmth to be related to vaccination with Infanrix. She considered the fever and rash to be possibly related to Infanrix.
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Feeling hot, Injection site reaction, Oedema
Clinical narrative: This case was reported by a nurse and described the occurrence of limb swelling in a 5-year old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix) for prophylaxis. On 08 July 2003, the patient received the fifth dose of Infanrix. Within 24 hours post-immunization on 09 July 2003, the patient experienced a "more than usual reaction" characterized by a "large amount" of swelling extending from shoulder to elbow, redness, and warmth. The patient was seen by the physician. The events resolved after an unspecified period of time. The nurse considered the events to be possibly related to vaccination with Infanrix.
Age: 6.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site warmth, Oedema peripheral
Clinical narrative: This case reported by a nurse and described the occurrence of limb swelling in a 6 year old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix) for prophylaxis. On 11 July 2003, the patient received Infanrix. One day post-immunization on 12-July 2003, the patient experienced limb swelling and an injection site reaction characterized by redness and warmth. The events persisted as of 16 July 2003.
Age: 1.5
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site warmth, Oedema peripheral
Clinical narrative: This case was reported by a nurse and described the occurrence of limb swelling in a 18 month old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 7/14/03, the patient received Infanrix. On 7/15/03, one day post immunization, the patient experienced limb swelling and an injection site reaction characterized by redness and warmth. The outcome of the events is unknown.
Age: 2.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Oedema peripheral
Clinical narrative: This case was reported by a nurse and described the occurrence of limb swelling in a 24 month old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 7/14/03, the patient received Infanrix. On 7/16/03, two days post immunization, the patient experienced limb swelling and an injection site reaction characterized by redness and warmth. The outcome of the events is unknown.
Age: 1.5
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site warmth, Oedema peripheral
Clinical narrative: This case was reported by a nurse and described the occurrence of limb swelling in an 18 month old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 7/9/03, the patient received Infanrix. On 7/10/03, one day post immunization, the patient experienced a more than usual reaction characterized by a large amount of swelling extending from shoulder to elbow, redness, and warmth. The patient was seen by the physician. The events persisted as of 7/16/03. Comment: The reporter indicated that two or three other patients experienced these events following receipt of Infanrix lot DTPA541E9. However, they are not identifiable.
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Injection site vesicles
Clinical narrative: This case described the occurrence of injection site pimples in a 4 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. This report was received from the patient's mother and has not bee verified by a physician or other health care professional. On 5/12/03 the patient received the second dose of Infanrix in the right thigh. On that date, she also received injections of inactivated poliomyelitis virus vaccine and Haemophilus influenzae type B conjugate vaccine. At an unknown time post-immunization, the patient reportedly experienced little pimples at the Infanrix injection site. The pimples resolved after three weeks. The mother declined to provide additional information and declined to grant authorization to contact the vaccine provider.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Dysuria, Hypersensitivity, Injection site erythema, Injection site swelling, Injection site vesicles
Clinical narrative: This case was reported by a nurse and described the occurrence of an allergic reaction in a 4 year old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The reporter submitted this report directly to VAERS. On 8/4/03, the patient received the 5th dose of Infanrix (lot DTPA598B2) in the left arm. On that date, the patient also received injections of inactivated poliomyelitis virus vaccine in the left arm and MMR in the right arm. Two days post immunization, on 8/6/03, the patient began to experience burning on urination, two blisters measuring 1cm on the left leg, and an injection site reaction characterized by blisters, redness, and swelling. The swelling extended from the left arm to the pectoral area. In the evening of 8/6/03, the patient was taken to the local emergency room. The emergency room physician made a diagnosis of allergic reaction and prescribed cephalexin. The events resolved after an unspecified period of time. The nurse considered the events were possibly related to vaccination with Infanrix.
Age: 1.4
Sex: F
Vaccine: DTAP
Symptoms: Cough, Drug ineffective
Clinical narrative: This case was reported by a physician and described the occurrence of pertussis in a 17 month old female patient who received tetanus and diphtheria toxoids and acellular pertussis vaccine absorbed for prophylaxis. On unspecified dates, the patient received two doses of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed; the second dose was Infanrix (lot DTPA542A2). The immunization series was delayed due to parental choice. On 4/4/02, the patient received injections of Haemophilus influenzae type B conjugate vaccine, inactivated poliomyelitis virus vaccine, hepatitis B vaccine, and 7-valent pneumococcal conjugate vaccine. On 7/21/03, the patient developed a persistent cough. At that time, there was an outbreak of pertussis where the patient lived. The patient was hospitalized. A diagnosis of pertussis was made and the patient was treated with erythromycin. Others in the same household had positive Bordatella pertussis cultures. The pertussis resolved on 8/31/03. The reporter considered that the event had jeopardized the patient. He also considered the event to be unrelated to Infanrix administration.
Age: 0.08
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia
Clinical narrative: This case was reported by a physician and described the occurrence of fever in a 7 week old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 10/1/02 the patient received the first dose of Infanrix. One day post immunization, on 10/2/02, the patient experienced fever. The patient was hospitalized. The event resolved after an unspecified period of time.
Age: 1.5
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This case was reported by a nurse and described the occurrence of an injection site reaction in an 18 month old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed for prophylaxis. On 14AUG2003 the patient received the 4th dose of Infanrix. On 15AUG2003, one day post -immunization, the patient developed an injection site reaction characterized by swelling and redness. The patient was seen in the emergency room and treated with diphenhydramine hydrochloride and paracetamol. On 19AUG2003, the events resolved. The physician considered the events were related to Infanrix lot 610A2.
Age: 1.6
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: This case was reported by a nurse and described the occurrence of an injection site reaction in a 19month old patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On 20August 2003 the patient received the 4th dose of Infanrix. On 22August 2003, two days post immunization, the patient presented to the physician with an injection site reaction characterized by redness and a "large" area of swelling. The events resolved. The nurse considered the events were related to Infanrix lot DTPA610A2.
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This case was reported by a physician and described the occurrence of an injection site reaction in a patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On an unspecified date, the patient received "the 2nd or 3rd" dose of Infanrix. At an unspecified time post-immunization, the patient developed an injection site reaction characterized by swelling and redness. As of 29 August 2003, the outcome of the event was unknown.
Sex: U
Vaccine: DTAP
Symptoms: Pain, Swelling
Clinical narrative: This case was reported by a nurse and described the occurrence of leg swelling in a patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. On an unspecified date in August 2003 the patient received a dose of Infanrix injected into a thigh. At an unknown time post -immunization, in August 2003, the patient experienced swelling of the injected leg. The patient's parent telephoned the physician, who prescribed an unspecified "pain reliever". The event resolved after an unspecified period of time. The nurse considered the event was probably related to vaccination with Infanrix. The reporter indicated that several patients experienced swelling of the injected leg or arm following receipt of Infanrix. However , they are not presently identifiable.
Age: 11.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Malaise, Medication error
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 11 year old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On an unspecified date, the patient received an injection of Infanrix, which is not recommended for immunizing individuals 7 years of age or older. On 9/10/03, at an unspecified time post immunization, the patient's parent telephoned the physician to report that the patient was experiencing fever, malaise, and an injection site reaction characterized by redness, swelling, and induration. The events resolved on an unspecified date prior to 9/17/03.
Age: 11.0
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 11 year old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On an unspecified date, the patient received an injection of Infanrix, which is not recommended for immunizing individuals 7 years of age or older. On 9/10/03, at an unspecified time post immunization, the patient's parent telephoned the physician to report that the patient was experiencing fever, malaise, and an injection site reaction characterized by redness, swelling, and induration. The events resolved on an unspecified date prior to 9/17/03.
Age: 0.3
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Irritability, Pyrexia
Clinical narrative: This case described the occurrence of fever in a 4 month old male patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine for prophylaxis. This report was initially received from the patient's mother. On 11/25/03, follow up was received from a nurse. On 9/22/03, the patient received injections of diphtheria and tetanus toxoids and acellular pertussis vaccine, hepatitis B vaccine, Haemophilus influenzae type B conjugate vaccine, inactivated poliomyelitis virus vaccine, and 7-valent pneumococcal conjugate vaccine. Later that day, at an unspecified time post immunization, the patient experienced slight fever and fussiness. The events resolved on 9/27/03. The nurse considered the events to be unrelated to vaccination with diphtheria and tetanus toxoids and acellular pertussis vaccine and hepatitis B vaccine.
Age: 2.0
Sex: M
Vaccine: DTAP
Symptoms: Discomfort, Injection site erythema, Injection site swelling, Oedema peripheral
Clinical narrative: A nurse reported the occurrence of an injection site reaction in a 26 month old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The patient had no relevant medical history, concurrent conditions, concurrent medications, or concurrent vaccinations. The patient had no adverse events following previous vaccinations. The patient received his fourth dose of Infanrix (lot DTPA610A2) in the left deltoid on 9/29/03. Two days later, on 10/01/03, he developed an injection site reaction characterized by redness, swelling, warmth, and itching. The swelling and redness extended from the shoulder to the elbow, and the area was uncomfortable. left arm circumference was 21cm; right arm was 16.5cm. The events resolved on 10/8/03. The nurse considered the events to be probably related to vaccination with Infanrix.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Malaise, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 4 year old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 9/12/03, the patient received an injection of Infanrix. On 9/15/03, three days post immunization, the patient's parent telephoned the physician to report that the patient was experiencing fever, malaise and an injection site reaction characterized by redness, swelling and induration. The events resolved on an unspecified date prior to 9/17/03.
Age: 1.5
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Malaise, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in an 18 month old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 9/2/03, the patient received an injection of Infanrix. On 9/10/03, eight days post-immunization, the patient's parent telephoned the physician to report that the patient was experiencing fever, malaise, and an injection site reaction characterized by redness, swelling, and induration. The events resolved on an unspecified date prior to 9/17/03.
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Malaise, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 5 year old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 9/9/03, the patient received an injection of Infanrix. On 9/10/03, one day post-immunization, the patient's parent telephoned the physician to report that the patient was experiencing fever, malaise, and an injection site reaction characterized by redness, swelling, and induration. The events resolved on an unspecified date prior to 10/8/03.
Age: 0.2
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Malaise, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 2 month old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 9/10/03, the patient received an injection of Infanrix. Later that day, at an unspecified time post immunization, the patient's parents telephoned the physician to report that the patient was experiencing fever, malaise and an injection site reaction characterized by redness, swelling, and induration. The events resolved on an unspecified date prior to 9/17/03.
Age: 1.6
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Malaise, Pyrexia
Clinical narrative: This case was reported by a nurse and described the occurrence of fever in a 19 month old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On 9/9/03, the patient received an injection of Infanrix. Later that day, at an unspecified time post immunization, the patient's parent telephoned the physician to report that the patient was experiencing fever, malaise, and an injection site reaction characterized by redness, swelling and induration. The events resolved on an unspecified date prior to 9/17/03.
Sex: U
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This case was reported by a nurse to a sales representative and described the occurrence of an injection site reaction in a child who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On an unspecified date, the patient received either the 18 month or 4 year dose of Infanrix. At an unspecified time post immunization, the patient developed an injection site reaction characterized by swelling and redness. The outcome of the event was unknown. Comment: The reporter indicated that three additional patient's experienced the same events following receipt of Infanrix during the same week. Each patient received the 18 month  or 4 year dose of vaccine. Identifiers are currently available for only one of these three patients.